Lanreotide

Post Date:
Aug 01,2017
Expiry Date:
Aug 01,2018
Detailed Description:
Cas No. :108736-35-2 Payment Method: T/T
Full Name：Lanreotide

Cas No：108736-35-2

Sequence：{D-2Nal}-Cys-Tyr-{D-Trp}-Lys-Val-Cys-Thr-NH2(disulfide bond Cys2&Cys7)

Molecular Formular: C54H69N11O10S2

Molecular Weight: 1096.32336 g/mol

Purity：≥98.0%

Here is the chemical structural formula

Lanreotide is mainly used in the management of acromegaly and symptoms caused by neuroendocrine tumors, most notably carcinoid syndrome
CAS Registry Number:
108736-35-2
Synonyms:
;B-naphthyl-D-ala-cys-tyr-D-trp*lys-val-cys-thr am;10-(4-aminobutyl)-N-(1-amino-3-hydroxy-1-oxobutan-2-yl)-16-(4-hydroxybenzyl)-13-(1H-indol-3-ylmethyl)-19-{[3-(naphthalen-2-yl)alanyl]amino}-6,9,12,15,18-pentaoxo-7-(propan-2-yl)-1,2-dithia-5,8,11,14,17-pentaazacycloicosane-4-carboxamide acetate (1:1);10-(4-aminobutyl)-N-(1-amino-3-hydroxy-1-oxobutan-2-yl)-16-(4-hydroxybenzyl)-13-(1H-indol-3-ylmethyl)-19-{[3-(naphthalen-2-yl)alanyl]amino}-6,9,12,15,18-pentaoxo-7-(propan-2-yl)-1,2-dithia-5,8,11,14,17-pentaazacycloicosane-4-carboxamide;Laromustine;
Molecular Formula:
C₅₄H₆₉N₁₁O₁₀S₂
Molecular Weight:
1096.34
Molecular Structure:

Offter to Sell